Ureter Injury clinical trials

Explore recruiting ureter injury clinical trials.

Recruiting ureter injury studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ureter Injury trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3 randomized controlled semi-blinded trial to investigate safety and effectiveness in visualization of the ureters with nizaracianine triflutate, administered intravenously in up to three divided doses, in participants (18 years or older) undergoing abdominopelvic surgical procedures [TRIPHASE Trial].

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Ureter Injury trials by city

Ureter Injury in Toronto Ureter Injury in Vancouver Ureter Injury in Montreal Ureter Injury in Calgary Ureter Injury in Edmonton Ureter Injury in Ottawa Ureter Injury in Winnipeg Ureter Injury in Quebec City Ureter Injury in Hamilton Ureter Injury in Kitchener Ureter Injury in London Ureter Injury in Halifax Ureter Injury in New York Ureter Injury in Los Angeles Ureter Injury in Chicago Ureter Injury in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease